Surgical adhesives have emerged as versatile alternatives to traditional sutures and staples, finding an increasing array of applications in the field of biosurgery.
The global Biosurgery Market was estimated to be worth US$ 13,887.5 Mn in 2021 and is anticipated to grow at a CAGR of 6.9% between 2022 and 2028 to reach US$ 22,212.9 Mn.,says Coherent Market Insights
Surgical adhesives, also known as tissue glues, are bioresorbable substances that bond tissues together, eliminating the need for stitches and reducing scarring. They offer several advantages, such as faster wound closure, reduced tissue trauma, and improved patient comfort during the healing process.
One of the primary drivers behind the growing adoption of surgical adhesives is the rising demand for minimally invasive procedures. These adhesives allow for precise and targeted wound closure without the need for extensive incisions, making them particularly valuable in laparoscopic and endoscopic surgeries.
The versatility of surgical adhesives extends beyond internal surgical applications. They are also used in wound closure for external injuries, such as lacerations and abrasions, and are particularly useful in cases where sutures may be challenging to apply or uncomfortable for the patient.
The aging population and the increasing prevalence of chronic diseases have contributed to the surge in surgeries performed worldwide. Surgical adhesives have played a pivotal role in meeting the demand for efficient wound closure, reducing the burden on healthcare facilities, and improving patient outcomes.
Advancements in adhesive technologies have led to the development of stronger, faster-acting, and more biocompatible products. Manufacturers are continuously investing in research and development to create innovative adhesives that meet the specific needs of various surgical procedures.
Furthermore, the benefits of surgical adhesives extend beyond their use in wound closure. They are increasingly being employed in tissue engineering and regenerative medicine applications, facilitating the development of bioactive scaffolds and promoting tissue repair and regeneration.
In terms of market growth, North America and Europe currently lead the adoption of surgical adhesives, owing to well-established healthcare infrastructures and high surgical procedure volumes. However, Asia-Pacific and Latin American regions are witnessing significant growth as well, attributed to increasing healthcare expenditure and a growing emphasis on improving healthcare access.
ENT chairs often have a reclining feature, allowing easy access to the patient's head and neck area.
The upholstery of ENT chairs is typically made of easy-to-clean and disinfect materials to maintain high hygiene standards.
In conclusion, surgical adhesives have become indispensable tools in the field of biosurgery, catering to the evolving needs of surgeons and patients alike. As medical technologies continue to progress and surgical practices become more focused on minimally invasive techniques, the demand for these adhesives is expected to witness further growth. Healthcare stakeholders should collaborate to ensure that these advanced biosurgical solutions are accessible to all patients, fostering better surgical outcomes and elevating patient care standards globally
